 The goal of the project is to establish that a single dose of AMPHOMUL can be used to achieve a Definitive cure for Visceral Leishmaniasis leading to a short course therapy. The project will also seek to establish that AMPHOMUL is safe, at least as effective and more affordable than current treatment, and is without the risk of drug resistance. 